NACFC 2020 | S24: Leveraging Lung Biology: Gateway to Therapy for All

Highly effective therapies for CFTR deficiency are available for 90% of CF patients. Unfortunately, the drugs testament not help all patients and in that location is a pressing need to address therapeutic strategies that for all individuals with CF. This symposium testament address innovative handling strategies and features of airway biology we need to understand to bring effective therapy to all.